CTT Pharmaceutical Holdings Inc CTTH
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.05–0.06
- 52-Week Range
- $0.04–0.10
- Bid/Ask
- $0.03 / $0.07
- Shares Outstanding
- 58.66M
- Market Cap
- $3.33M
- Volume/Avg
- 20,300 / 42,566
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The company's technology platform includes the development of oral delivery thin wafers to deliver treatment as an alternative to smoking and ingestion. This technology platform target both the human and veterinarian(pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in majorly markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the USA, Canada, Europe and many other countries across the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
Valuation
|
Metric
|
CTTH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 129.82 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CTTH
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | — |
Quick Ratio
CTTH
Profitability
|
Metric
|
CTTH
|
|---|---|
Return on Assets (Normalized) | −190.38% |
Return on Equity (Normalized) | −289.04% |
Return on Invested Capital (Normalized) | −219.04% |
Return on Assets
CTTH
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|KW^$%GH | LOCK|HX>#b | $68B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|MT>qpT! | LOCK|#>ttZ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|&bJt>$J | LOCK|$VX | $39B | |||
| Zoetis Inc Class A
ZTS
| LOCK|>S!w>$& | LOCK|B! | $29B | |||
| Viatris Inc
VTRS
| LOCK|G>H#ljP | LOCK|fg | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^CS | LOCK|@f | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|NWlw%^% | LOCK|#@ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|sr$pwF | LOCK|T# | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|$<F#mq | LOCK|@CCW | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|WxLT?N | LOCK|s! | $2B |
United States